Form 8-K - Current report:
SEC Accession No. 0001628280-24-052009
Filing Date
2024-12-19
Accepted
2024-12-19 12:29:21
Documents
14
Period of Report
2024-12-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jan-20241218.htm   iXBRL 8-K 48055
2 EX-99.1 exh991_alt5sigmaannouncesr.htm EX-99.1 20369
  Complete submission text file 0001628280-24-052009.txt   204625

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jan-20241218.xsd EX-101.SCH 1810
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jan-20241218_lab.xml EX-101.LAB 22804
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jan-20241218_pre.xml EX-101.PRE 13069
16 EXTRACTED XBRL INSTANCE DOCUMENT jan-20241218_htm.xml XML 2824
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 241561786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)